Language: English
Keywords: AbbVie, blocked, access, website, grey, red cross, browser window
Layout: Header with text, browser window with red cross
ColorStyle: Grey, white, red
Overview: This website displays a message indicating that the user has been blocked and is unable to access abbvie.com. The layout consists of a grey header with the text 'Sorry, you have been blocked' and 'You are unable to access abbvie.com'. Below the header, there is a section resembling a computer browser window with a grey border and a red cross in the center, symbolizing a block or error message. The color scheme primarily consists of shades of grey and white, with the red cross providing a contrasting element.
abbvie.com was registered 1 decade 2 years ago. It has a alexa rank of #56,094 in the world. Its bounce rate is 47.10%. There are about 3.80 page views per visit. It is a domain having .com extension. It is estimated worth of $ 270,000.00 and have a daily income of around $ 375.00. As no active threats were reported recently, abbvie.com is SAFE to browse.
Daily Unique Visitors: | 31,260 |
Daily Pageviews: | 187,560 |
Income Per Day: | $ 375.00 |
Estimated Worth: | $ 270,000.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | 16,800 |
Bing Indexed Pages: | 11,800 |
Google Backlinks: | Not Applicable |
Bing Backlinks: | 5,080 |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 56,094 |
PageSpeed Score: | 62 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | 47.10% |
Time On Site: | 2:44 |
Total Traffic: | No Data |
Direct Traffic: | No Data |
Referral Traffic: | No Data |
Search Traffic: | No Data |
Social Traffic: | No Data |
Mail Traffic: | No Data |
Display Traffic: | No Data |
As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which...
Authorized Users Only. Only authorized AbbVie personnel are allowed to access this system. By accessing this system as an AbbVie user you acknowledge that all …
For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn . The Medical Science Liaison (MSL)...
Effective January 1, 2019, VIEKIRA XR and TECHNIVIE will no longer be available in the U.S.A. Until January 1, 2019, supply of these medications will be available for all...
May 07, 2020 · NORTH CHICAGO, Ill., May 8, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its...
The Investor Relations website contains information about AbbVie's business for stockholders, potential investors, and financial analysts.
2 days ago · On October 19, 2020, AbbVie Inc. issued a press release announcing the commencement of its offers to exchange any and all of its outstanding (i) $30,000,000,000...
H1 Headings: | 1 | H2 Headings: | 22 |
H3 Headings: | 7 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 18 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
If you experience Chronic Migraine, you know it's not just a headache. Visit our website to learn more so you can speak with you doctor about treatment options
Learn about Crohn’s and UC, the two most common inflammatory bowel diseases. Get information, resources and understand the differences between Crohn's and Colitis.
Learn about Synthroid® (levothyroxine sodium tablets,USP), how to take it, support & savings. See Use & Important Safety Information, including BOXED WARNING.
Domain Registrar: | MarkMonitor Inc. |
---|---|
Registration Date: | 2012-02-29 1 decade 2 years 8 months ago |
Last Modified: | 2019-01-27 5 years 9 months 3 weeks ago |
Host | IP Address | Country | |
---|---|---|---|
abvegdmzns1.abbvie.com | 159.180.132.57 | Brazil | |
abvludmzns1.abbvie.com | 159.180.162.57 | Brazil | |
abvsgdmzns1.abbvie.com | 159.180.178.57 | Brazil |
Host | Type | TTL | Extra |
---|---|---|---|
abbvie.com | A | 278 |
IP: 159.180.132.176 |
abbvie.com | NS | 3600 |
Target: abvegdmzns1.abbvie.com |
abbvie.com | NS | 3600 |
Target: abvludmzns1.abbvie.com |
abbvie.com | NS | 3600 |
Target: abvsgdmzns1.abbvie.com |
abbvie.com | SOA | 3600 |
MNAME: abvegdmzns1.abbvie.com RNAME: domainadmins.abbvie.com Serial: 2018041061 Refresh: 1800 Retry: 900 Expire: 1209600 |
abbvie.com | MX | 300 |
Priority: 20 Target: cluster1a.us.messagelabs.com |
abbvie.com | MX | 300 |
Priority: 10 Target: cluster1.us.messagelabs.com |
abbvie.com | TXT | 3600 |
TXT: adobe-idp-site-verification=c28a4333875b 49fb1c8bdc1fc5bcaa8ab0f6c189de97f2308aee 0dbae96c7e79 |
abbvie.com | TXT | 3600 |
TXT: webexdomainverification.275G2=f9995e66-3 d81-4198-98c6-49af621378a4 |
abbvie.com | TXT | 86400 |
TXT: MS=ms21755855 |
abbvie.com | TXT | 3600 |
TXT: google-site-verification=7LmZ4B6Td_KyX_e nVAcZVTLDb-RO0FIf77_GYiSDCHQ |
abbvie.com | TXT | 3600 |
TXT: webexdomainverification.JUDP=9ff51131-bd cc-4443-a98b-bb4a9a3a7882 |
abbvie.com | TXT | 3600 |
TXT: v=spf1 include:spf.protection.outlook.com include:spf.messagelabs.com include:_spf.abbvie.com include:_spf1.abbvie.com include:_spf2.abbvie.com -all |
abbvie.com | TXT | 3600 |
TXT: adobe-sign-verification=94bd2c9b70257643 36d4f751c4ff67aa |
abbvie.com | TXT | 3600 |
TXT: MS=ms71003153 |
abbvie.com | TXT | 3600 |
TXT: A0B2B85245 |
abbvie.com | TXT | 86400 |
TXT: google-site-verification=rW3kfY6uvaXdldC _GcvHuszf6PcQ_A71XCturpcs9B4 |
abbvie.com | TXT | 3600 |
TXT: 4C6k/kGlDrhQxCbDYrYCfNLImNzQOVhPOivN79ew Qxi7APsEl/pq/xXYHlo8Y1Uxzwh3vzzitGDKV0jz T2jnPw== |
abbvie.com | TXT | 3600 |
TXT: atlassian-domain-verification=jYFr5Ubbph 5ao+EmkgwO1HLJDbbZOMgimkVh4YPn9sMespyvN9 nRLSAVitwtYV8n |
abbvie.com | TXT | 3600 |
TXT: webexdomainverification.F0XJ=7fd93f1e-7c 4b-4fe1-9104-e0e6e8da4e68 |
abbvie.com | TXT | 3600 |
TXT: webexdomainverification.4C675B8ADD6AB136 E053AB06FC0A3F65=ad91b7fb-136a-4db4-a9bf -f2e90db03835 |
abbvie.com | TXT | 3600 |
TXT: webexdomainverification.5c569c43d56deac6 e053ab06fc0a4b3d=579f9f98-bfb1-4e6e-bf02 -000646097c7b |
abbvie.com | TXT | 3600 |
TXT: webexdomainverification.2IWS2=9fc3e43f-d 12a-49a5-add6-523477a9ae3a |
abbvie.com | TXT | 3600 |
TXT: cloudbees-domain-verification=ce1d76367c 04d17e18d4b6cd8e47845952134847 |
Country Name | Percent Traffic | Rank In Country |
---|---|---|
United States | 64.7% | 14,412 |
Japan | 16.3% | 18,554 |
United Kingdom | 5.3% | 28,000 |
India | 4.7% | 52,087 |
Saudi Arabia | 1.1% | 27,254 |
1. abbvie | 29.81% |
2. abbvie careers | 3.26% |
3. abbvie inc | 3.10% |
4. elagolix | 2.13% |
5. abbvie investor relations | 1.59% |
federation.abbvie.com | 61.20% |
abbvie.com | 30.09% |
idp.abbvie.com | 19.15% |
cte.abbvie.com | 12.09% |
connect.abbvie.com | 11.45% |
Site | Url |
---|---|
blog.jp | http://marketss.blog.jp/archives/52276594.html |
harvard.edu | http://dfhcc.harvard.edu/events/pipelines-in-oncology-seminar-series |
berkeley.edu | http://cchem.berkeley.edu/pabgrp/People/Former.html |
cornell.edu | http://bonassar.research.engineering.cornell.edu/research-areas_v2/cartilage-repair-mechanics |
illinois.edu | http://mcb.illinois.edu/undergrad/advising/career_services |
Official Online Store featuring James Perse Los Angeles designer collections for men, women, home.
Discover cutting-edge home and industrial appliances across laundry solutions, kitchen solutions, and living solutions that will set you free.
Convert.com’s A/B testing tool has split testing, personalization, advanced goals, fast support, and monthly payments.